Secant Lifesciences (India) Private Limited.
Trading biotech products and medical equipment since 2006, based in Delhi.
2006 | Delhi (India) | Active
Secant Lifesciences (India) Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 18 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.40 Cr
- Revenue Growth -46.68%
- Profit Growth -78.71%
- Ebitda -35.97%
- Net Worth 4.38%
- Total Assets 5.54%
About Secant Lifesciences (India)
Secant Lifesciences (India) Private Limited. (SLIPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 May 2006 and has a history of 18 years and nine months. Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹2.40 Cr.
Dheeraj Gahlaut and Sangeeta Joon serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85121DL2006PTC149009
- Company No.
149009
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 May 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Healthcare
Who are the key members and board of directors at Secant Lifesciences (India)?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dheeraj Gahlaut  | Director | 21-May-2006 | Current |
| Sangeeta Joon | Additional Director | 27-Aug-2020 | Current |
Financial Performance of Secant Lifesciences (India).
Secant Lifesciences (India) Private Limited., for the financial year ended 2021, experienced significant reduction in revenue, with a 46.68% decrease. The company also saw a substantial fall in profitability, with a 78.71% decrease in profit. The company's net worth moved up by a moderate rise of 4.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Secant Lifesciences (India)?
In 2021, Secant Lifesciences (India) had a promoter holding of 50.00% and a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Tej Agro Products Llp
Dheeraj Gahlaut and Sangeeta Joon are mutual person
Charges (Loans)
Open Charges
₹24.04 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Others : 1.60 Cr
- Dena Bank : 0.80 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Jan 2023 | Others | ₹0.26 M | Open |
| 23 Jan 2023 | Others | ₹1.90 M | Open |
| 15 Jul 2020 | Others | ₹5.60 M | Open |
| 22 Aug 2018 | Others | ₹5.25 M | Open |
| 07 Apr 2017 | Others | ₹3.03 M | Open |
How Many Employees Work at Secant Lifesciences (India)?
Unlock and access historical data on people associated with Secant Lifesciences (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Secant Lifesciences (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Secant Lifesciences (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
